Prognostic relevance of promoter methylation-associated loss of ID4 expression in glioblastoma multiforme. IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a ...

A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma No significant financial relationships to disclose. This is an ASCO ...

Brain metastases are commonly treated with surgery plus whole-brain radiation therapy (WBRT), but WBRT carries a substantial risk of neurocognitive decline. A study published in Cancer has shown that ...

Chemotherapy is most often given as an infusion into a vein (intravenously). However, in one of the rare cases, city doctors implanted medicated wafers (Gliadel) right into brain. These wafers contain ...

MGI PHARMA, INC. (Nasdaq: MOGN) today announced the publication of long-term (56 month) follow-up data showing that Gliadel® Wafer provides a durable long-term survival benefit for patients with ...

Eisai Co., Ltd., a US subsidiary of Eisai Inc. has entered into a definitive asset purchase agreement to divest US rights for its Gliadel Wafer (carmustine intracranial implant wafer), an ...

Find out how to take Polifeprosan 20 with Carmustine (drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.

Learn the correct pronunciation of the Polifeprosan 20 with Carmustine, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special ...